U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C16H21NO4
Molecular Weight 291.3422
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BEFUNOLOL

SMILES

CC(C)NCC(O)COC1=CC=CC2=C1OC(=C2)C(C)=O

InChI

InChIKey=ZPQPDBIHYCBNIG-UHFFFAOYSA-N
InChI=1S/C16H21NO4/c1-10(2)17-8-13(19)9-20-14-6-4-5-12-7-15(11(3)18)21-16(12)14/h4-7,10,13,17,19H,8-9H2,1-3H3

HIDE SMILES / InChI

Molecular Formula C16H21NO4
Molecular Weight 291.3422
Charge 0
Count
Stereochemistry RACEMIC
Additional Stereochemistry No
Defined Stereocenters 0 / 1
E/Z Centers 0
Optical Activity ( + / - )

Befunolol is a beta-adrenergic receptor blocker approved in Japan for the treatment of open-angle glaucoma. The current drug status is unknown.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
8.97 null [pKd]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
BENTOS

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Aqueous humor dynamics in beagle dogs with caffeine-induced ocular hypertension.
1998 Jun
Contact dermatitis to topical drugs for glaucoma.
2001 Dec
Human corneal equivalent as cell culture model for in vitro drug permeation studies.
2004 Apr
Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas.
2005 Jul
Utilization of 4-chloro-7-nitro-2,1,3-benzoxadiazole (NBD-Cl) for kinetic spectrophotometric assay of befunolol hydrochloride in its pharmaceutical formulation.
2006 May-Jun
Allergic contact dermatitis due to levobunolol with cross-sensitivity to befunolol.
2007 Jan
Pharmacological evaluation of ocular beta-adrenoceptors in rabbit by tissue segment binding method.
2009 Jan 30
Reconstruction of a human cornea by the self-assembly approach of tissue engineering using the three native cell types.
2010 Oct 29
Patents

Patents

Sample Use Guides

1% solution 2 times daily.
Route of Administration: Other
In Vitro Use Guide
Sources: www.ncbi.nlm.nih.gov/pubmed/15031177
Human cornea construct was used to test befunolol (0,5%) permeability.The permeation coefficient was 9,88*10(-6) cm/s.
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:03:22 UTC 2023
Edited
by admin
on Fri Dec 15 16:03:22 UTC 2023
Record UNII
418546MT3A
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BEFUNOLOL
INN   MI   WHO-DD  
INN  
Official Name English
befunolol [INN]
Common Name English
Befunolol [WHO-DD]
Common Name English
7-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)-2-BENZOFURANYL METHYL KETONE
Systematic Name English
BEFUNOLOL [MI]
Common Name English
2-ACETYL-7-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)BENZOFURAN
Systematic Name English
Classification Tree Code System Code
WHO-ATC S01ED06
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
WHO-VATC QS01ED06
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
NCI_THESAURUS C29576
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
NCI_THESAURUS C29705
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
Code System Code Type Description
PUBCHEM
2309
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
CAS
39552-01-7
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
EPA CompTox
DTXSID80865957
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
INN
4452
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
SMS_ID
100000086134
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
ChEMBL
CHEMBL153984
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
DRUG CENTRAL
295
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
WIKIPEDIA
BEFUNOLOL
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
DRUG BANK
DB09013
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
FDA UNII
418546MT3A
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
EVMPD
SUB05682MIG
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
MESH
C006034
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
NCI_THESAURUS
C73021
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY
MERCK INDEX
m2291
Created by admin on Fri Dec 15 16:03:22 UTC 2023 , Edited by admin on Fri Dec 15 16:03:22 UTC 2023
PRIMARY Merck Index
Related Record Type Details
SALT/SOLVATE -> PARENT
ENANTIOMER -> RACEMATE
ENANTIOMER -> RACEMATE
Related Record Type Details
ACTIVE MOIETY